$IPAR

Is Interparfums (IPAR) Undervalued After Its PUMA Fragrance Licensing Deal?

Interparfums (IPAR) signed a deal to create and distribute PUMA-branded fragrances through 2037. The stock has seen a 38.03% YTD return but trades 7% below the average analyst target. Analysts consider it undervalued with a fair value estimate of $126.67, citing its licensing model and portfolio expansion.

Original reporting
Published Sep 27, 2026, 1:25 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 27, 2026, 3:14 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Is Interparfums (IPAR) Undervalued After Its PUMA Fragrance Licensing Deal? — source image
Decision brief

The 30-second read

$IPARBullishMed
01

Why it matters

The new PUMA partnership extends the company's licensing portfolio, potentially enhancing revenue and earnings stability.

02

Market read

A fresh licensing deal for a mid‑cap consumer discretionary stock; may attract short‑term buying interest.

03

What to watch

Execution risk, cost of product development, and potential cannibalization of existing fragrance lines.

Relevance 6/10Novelty 6/10Timing: post‑announcement today

Background

Interparfums (NASDAQ:IPAR) is a fragrance company that grows through brand licensing agreements.

Company-level read

Ticker impact

$IPARBullishMedium confidence
Context

Interparfums announced an exclusive worldwide licensing deal with PUMA to create fragrances through 2037, a fresh corporate development.

Expected impact

upward pressure as investors price in additional licensing revenue

Evidence & confidence

Licensing deals historically boost top‑line growth for fragrance companies; the deal spans a decade, giving sustained upside.

Market effects

May lift other fragrance and consumer‑goods licensors as investors reassess licensing pipelines.

European luxury market could see modest upside from expanded brand collaborations.

Limited to consumer discretionary sector; not a broad market driver.

Counterpoint

If PUMA's brand fails to resonate in fragrance, the deal could dilute margins and pressure the stock.

Key entities

  • Interparfums

    Fragrance licensor announcing the PUMA deal.

  • PUMA

    Sportswear brand granting fragrance licensing rights.

Related articles

$IPARMed

Is Interparfums’ (IPAR) New Global Fragrance Deal a Game-Changer?

Interparfums (IPAR) announced a 10-year deal with PUMA to create and distribute fragrances, starting in 2027. The company reported Q2 sales growth of 2% to $341M, but operating income fell 17% to $49M. IPAR has a strong balance sheet with $169.7M in cash and a 18.4% return on invested capital. The stock trades at a forward P/E of 23.64, with 10.80% short interest.

Med

How Softer Half Year Earnings At Interparfums (ENXTPA:ITP) Has Changed Its Investment Story

Interparfums SA reported H1 2026 sales of €414.29M and net income of €65.46M, both down from the prior year. Lower EPS and profit margins raised concerns about demand and cost control. The company's investment narrative is under scrutiny, with near-term focus on brand demand, pricing power, and cost discipline. Revenue and earnings growth are expected in the mid-single digits.

$IPARMed

Inter Parfums (NASDAQ:IPAR) Posts Better

Inter Parfums (NASDAQ:IPAR) reported Q2 CY2026 revenue of $341 million, up 2.1% year on year and 0.6% above market expectations, according to the company. Full-year revenue guidance was $1.48 billion at the midpoint, 1.5% below analysts’ estimates. GAAP EPS was $0.95, 2.1% below consensus. The stock was flat at $128.43 after results.